1. Home
  2. ATRO vs PGEN Comparison

ATRO vs PGEN Comparison

Compare ATRO & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astronics Corporation

ATRO

Astronics Corporation

N/A

Current Price

$54.99

Market Cap

2.4B

Sector

Industrials

ML Signal

N/A

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$4.21

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATRO
PGEN
Founded
1968
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.8B
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
ATRO
PGEN
Price
$54.99
$4.21
Analyst Decision
Buy
Buy
Analyst Count
5
4
Target Price
★ $91.75
$13.67
AVG Volume (30 Days)
517.4K
★ 6.8M
Earning Date
11-10-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 276.09
N/A
EPS
★ 2.36
0.12
Revenue
★ $862,128,000.00
$230,981,000.00
Revenue This Year
$19.65
$2,380.31
Revenue Next Year
$12.42
$84.01
P/E Ratio
★ $24.71
$34.63
Revenue Growth
★ 8.39
N/A
52 Week Low
$47.58
$3.04
52 Week High
$99.89
$8.98

Technical Indicators

Market Signals
Indicator
ATRO
PGEN
Relative Strength Index (RSI) 40.91 31.74
Support Level $54.10 $3.89
Resistance Level $63.72 $4.41
Average True Range (ATR) 4.07 0.36
MACD 0.10 -0.01
Stochastic Oscillator 28.19 16.78

Price Performance

Historical Comparison
ATRO
PGEN

About ATRO Astronics Corporation

Astronics Corporation is a provider of technologies to the aerospace, defense, and electronics industries, offering high-performance electrical power generation and distribution systems, motion systems, lighting and safety systems, avionics products, systems certification, aircraft structures, and automated test systems. The company operates through two reportable segments, Aerospace and Test Systems. The Aerospace segment designs and manufactures products for the aerospace and defense industry and generates the majority of revenue, while the Test Systems segment designs, develops, manufactures, and maintains automated test systems for the aerospace and defense, communications, and mass transit industries. The company derives the majority of its revenue from the United States.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: